What makes sarcopenia during cancer treatment so difficult to prevent is that it is not a single problem with a single fix. Its development reflects interacting nutritional, inflammatory, metabolic, immune, behavioural, and functional disturbances, all unfolding against the backdrop of a demanding treatment schedule. In nasopharyngeal carcinoma, toxicities affecting oral intake, swallowing, and salivary function during radiotherapy compound these processes, driving progressive deterioration in nutritional status, physical activity, and daily functioning. Because risk and supportive care needs shift across the treatment trajectory, a preventive strategy that works in week one may be inadequate by week six. Yet current approaches remain fragmented, often delivered as isolated interventions targeting one aspect of care at a time. Nutritional supplementation, the most common strategy, plays an essential role in maintaining energy and protein intake, but interventions focused on nutrition alone may be insufficient to address the complex and evolving factors contributing to muscle loss during definitive treatment.

A research team led by Lijuan Xia of the General Hospital of Ningxia Medical University in China, working with colleagues including Naoko Hayashi of St. Luke’s International University in Tokyo, has now tackled this gap head-on. Writing in the journal Supportive Care in Cancer, they report the development of a context-sensitive supportive care pathway designed to coordinate multidisciplinary sarcopenia prevention across the entire nasopharyngeal carcinoma treatment trajectory. Crucially, the study does not claim to prove that the pathway works. Instead, its contribution lies in providing a transparent, theoretically informed account of how such a pathway should be built, drawing together evidence, theory, stakeholder perspectives, and real-world constraints before any effectiveness testing begins. The work was guided by the updated Medical Research Council framework for developing and evaluating complex interventions, a methodological blueprint that emphasises integrating multiple sources of knowledge through iterative refinement.

The development process was anchored by a multidisciplinary team of thirteen healthcare professionals: four physicians, four nurses, two dietitians, one physiotherapist, one clinical pharmacist, and one psychologist, each with at least fifteen years of professional experience and senior rank in their discipline. This team served as the core decision-making body, appraising candidate components, adapting them to local conditions, and finalising the operational structure across two formal face-to-face meetings held in February and March 2025. Foundational inputs came from five complementary activities: a systematic review of non-pharmacological interventions, semi-structured interviews with healthcare professionals, economic and resource considerations, programme theory development, and contextual analysis. The systematic review included 21 randomised controlled trials reported in 22 publications, all conducted in China, and revealed a strikingly uneven evidence base. Evidence was most extensive for nutritional interventions, while exercise and probiotic approaches were supported by fewer, more heterogeneous studies.

The qualitative component provided the implementation intelligence that evidence alone cannot supply. Of 26 healthcare professionals invited, 21 participated in interviews conducted between January and February 2025, spanning five physicians, seven nurses, three dietitians, two physiotherapists, two clinical pharmacists, and two psychologists. Reflexive thematic analysis, informed by the Theoretical Domains Framework as a sensitising lens, generated three overarching themes comprising eleven subthemes: knowledge and competency gaps, structural and implementation barriers, and key intervention suggestions. Participants described limited recognition of sarcopenia, unclear professional responsibilities, and fragmented multidisciplinary care. For pathway development, these findings were synthesised into four cross-cutting implementation requirements: recognition and professional competency, care organisation and multidisciplinary coordination, longitudinal monitoring and continuity of care, and patient self-management and family-supported care. Each requirement was mapped directly to a design response in the final pathway, creating an auditable link between what clinicians said was missing and what the pathway delivers.

Resource realities shaped several pragmatic decisions. Routine vitamin D supplementation was not adopted; it was restricted to patients with documented deficiency, following locally approved laboratory and clinical procedures. Probiotic support was retained as a context-adaptable rather than universally fixed component, because the formulations evaluated in nasopharyngeal carcinoma trials were not fully matched by locally available products, and similar products had limited routine affordability. Repeated specialised immunological testing was judged too resource-intensive for routine longitudinal care, so the team instead selected pragmatic supplementary monitoring measures derived from routinely collected clinical parameters, including the global immune-nutrition-inflammation index, the HALP score combining hemoglobin, albumin, lymphocyte, and platelet counts, and the prognostic nutritional index. These indices were not used as standalone diagnostic thresholds; their trends were interpreted alongside body weight, oral intake, symptoms, and treatment tolerance to inform reassessment and escalation decisions.

The final pathway rests on three interconnected structural elements. First, it specifies discipline-specific roles within a coordinated multidisciplinary workflow: physicians oversee clinical assessment and medical management, nurses conduct comprehensive assessment and education while coordinating communication, dietitians adjust individualised nutritional plans, physiotherapists assess function and guide safe activity, psychologists manage distress and support behavioural adaptation, and clinical pharmacists support symptom and medication management. Second, it defines six longitudinal care procedures: assessment and individualised planning, one-to-one education, weekly monitoring, multidisciplinary consultation for complex or escalating needs, scheduled multidisciplinary reassessment at key treatment time points, and an end-of-treatment review with a care summary. Third, it organises supportive care into five strategic domains: nutritional and immune management, exercise management, head and neck symptom cluster management, gastrointestinal symptom cluster management, and psycho-behavioural support.

Two operational features deserve particular attention. The pathway embeds a risk stratification system based on the 2019 Asian Working Group for Sarcopenia criteria, using bioelectrical impedance analysis to measure appendicular skeletal muscle mass index, handgrip strength, and six-metre gait speed. Low muscle mass with preserved strength and performance is treated as a pathway-level early-warning state, while body-weight losses of 2.5 percent and 5 percent from baseline serve as pragmatic triggers for early multidisciplinary review and further escalation of support respectively. The team is careful to note these thresholds are pathway triggers, not universally validated diagnostic cut-offs. Meanwhile, the psycho-behavioural domain is grounded in the theory of planned behaviour: education, goal setting, tailored feedback, and family reinforcement are designed to strengthen patients’ attitudes, perceived social norms, and sense of behavioural control, which in turn are hypothesised to improve adherence to nutritional, exercise, and symptom-management recommendations and ultimately preserve muscle mass, strength, and function.

Patient and family voices entered the process through informal consultations with six patients undergoing or recently completing definitive treatment and six family caregivers. Most participants were initially unfamiliar with the term sarcopenia and, after explanation by nursing staff, tended to relate it to the more familiar concept of malnutrition. Their feedback centred on practical needs, particularly nutritional support, physical activity, home-based self-management, and family involvement, and informed refinements to one-to-one education and caregiver engagement. The researchers are candid about limitations: the study did not evaluate feasibility or effectiveness, the evidence base for individual components was uneven, development was situated within the Chinese healthcare context, and patient involvement was consultative rather than a formal co-development partnership. A pilot randomised controlled trial protocol has since been published to operationalise the pathway for feasibility testing. The team’s central message stands: sarcopenia prevention during cancer treatment should be conceived not as a series of isolated interventions, but as a coordinated, longitudinal, multidisciplinary process, one that treats prevention as dynamic risk management rather than episodic repair.

Subject of Research: Development of a multidisciplinary supportive care pathway for sarcopenia prevention in patients with nasopharyngeal carcinoma undergoing definitive treatment

Article Title: Developing a supportive care pathway for sarcopenia prevention in nasopharyngeal carcinoma: a context-sensitive and implementation-oriented approach

Article References: Xia, L., Chen, S., Min, J., Ma, Z., Zhang, Y., Zhang, F., Liu, S., Yan, B., & Hayashi, N. (2026). Developing a supportive care pathway for sarcopenia prevention in nasopharyngeal carcinoma: a context-sensitive and implementation-oriented approach. Supportive Care in Cancer, 34(10), Article 1058. https://doi.org/10.1007/s00520-026-11242-4

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11242-4

Keywords: sarcopenia, nasopharyngeal carcinoma, supportive care, multidisciplinary care, cancer nutrition, exercise oncology, implementation science, Medical Research Council framework, chemoradiotherapy, patient self-management, symptom management, complex interventions

The scale of the problem gives the findings urgency. Chronic kidney disease is defined by structural or functional abnormalities of the kidneys lasting more than three months, or by a decline in the glomerular filtration rate below 60 mL/min/1.73 m². Under the international KDIGO 2012 guidelines, the disease is staged from G1 to G5 by filtration rate and further risk-stratified by albuminuria, with the most advanced cases—those with a filtration rate below 20—requiring renal replacement therapy. Mortality is projected to rise by more than 30 percent between 2022 and 2050, and in Spain, where the review team is based, an estimated one in seven adults lives with the disease, a figure comparable to the United States. Diabetes, hypertension, obesity, cardiovascular disease and age over 60 are the principal risk factors, and lower socioeconomic status compounds the risk.

Quality of life, and specifically health-related quality of life, is the outcome that matters most to patients, yet it is consistently depressed in this population. Compared with healthy individuals, people with chronic kidney disease report reduced physical activity, impaired sexual function, diminished occupational capacity and worse general health, effects that deepen with age and comorbidities. The review’s authors asked a deceptively simple question using the PICO framework: in adults with chronic kidney disease, does health education increase quality of life compared with no education? To answer it, they searched PubMed, the Virtual Health Library and EBSCOhost for studies published between 2014 and 2024, screening 940 records and, after applying inclusion and exclusion criteria, retaining twelve studies for the final synthesis.

The twelve studies fell into four intervention categories that the authors describe as intermediate mechanisms linking education to quality of life: nutrition and fluid management, physical activity, self-management and disease knowledge, and emotional intelligence. Nine were randomized controlled trials, two were quasi-experimental, and one was a single-arm pre-post study. The nutritional trials were among the most revealing. In a randomized trial of 87 hemodialysis patients, individualized dietary advice significantly reduced sodium intake from 90 days onward, along with consumption of packaged seasonings, processed meat and instant noodles, although quality of life itself did not change significantly between groups. Another trial delivered nutrition education virtually, through a Telegram messaging channel, and found that patients not only improved their quality of life but also lowered their serum potassium, sodium, phosphorus and magnesium levels.

The physical activity studies added a striking technological dimension. In the Kidney BEAM trial, 268 patients in the United Kingdom were randomized to a twelve-week digital renal rehabilitation program with live and pre-recorded exercise sessions, or to standard care. The digital group showed significant gains in the mental component of quality of life, patient activation, social function, energy and sit-to-stand performance, and a reduction in the perceived burden of kidney disease—yet the physical component score itself did not change significantly. A Chinese trial of home-based aerobic exercise, by contrast, improved both physical and mental quality of life domains, along with walking capacity, sit-to-stand performance, exercise self-efficacy and anxiety scores. The contrast suggests that intensity and individualization, not the delivery medium, may determine whether physical benefits follow.

Perhaps the most consistent pattern across the synthesis was the divergence between mental and physical improvement. In several studies measuring both components separately—including the digital rehabilitation trial, the self-management program and the peritoneal dialysis retraining study—the mental component of quality of life improved more reliably and to a greater degree than the physical component. The exceptions were instructive: the three studies that found significant gains in both domains combined structured physical activity or nutritional components with individualized, higher-intensity delivery. The authors propose that this differential pattern, rarely addressed explicitly in earlier reviews, reflects the nature of the interventions themselves rather than unexplained inconsistency in the evidence.

Self-management and emotional intelligence programs produced some of the most encouraging results. A twelve-week Australian intervention grounded in social-cognitive theory, combining face-to-face sessions, motivational interviewing and telephone follow-up, improved self-efficacy, disease knowledge, fruit and vegetable consumption and communication with healthcare providers, while reducing alcohol intake, blood pressure and depression and stress scores. In hemodialysis patients, an emotional intelligence program built around self-awareness, self-control, empathy, self-motivation and social skills raised all five domains significantly and improved quality of life at six and twelve weeks. A Bangladeshi trial combining an awareness campaign with mobile health technologies, leaflets and weekly home visits increased disease knowledge and improved blood pressure, body mass index and dietary salinity—though, notably, quality of life measured with the generic EQ-5D-5L instrument showed no significant effect in any analysis.

That last finding points to one of the review’s most practical insights: the choice of measurement instrument matters enormously. In the Kidney BEAM trial, the same patients showed significant improvement on the disease-specific KDQoL-SF questionnaire but not on the generic EQ-5D-5L, suggesting that generic instruments may be less sensitive to change in this population. The authors argue that future trials should adopt validated, kidney-specific quality-of-life measures to avoid false negatives. They also flag findings that did not reach significance rather than burying them: the sodium-restriction trial found no between-group quality-of-life difference, and one Saudi study even reported that the control group scored better on the pain domain of the SF-36, a counter-intuitive result the original publication had not discussed.

The review is candid about the weakness of its evidence base. Applying the Cochrane RoB2 and ROBINS-I tools, the authors rated most studies as having some concerns or high risk of bias, and a simplified GRADE assessment judged the certainty of evidence for the mental component of quality of life to be low and for the physical component very low. Heterogeneity was substantial: six different quality-of-life instruments were used across studies of hemodialysis, peritoneal dialysis and non-dialysis patients, making statistical pooling inappropriate. The review itself was not prospectively registered, was limited to free full-text English and Spanish publications, and could not formally assess publication bias, although the predominance of positive findings raises that possibility. The authors conclude that the results should be interpreted as suggestive rather than conclusive.

Even with those caveats, the direction of the evidence is hard to ignore. Educational interventions were associated with improvements in blood pressure, serum electrolytes, physical function, depression and anxiety in most studies, and patients who received education consistently fared better than those on standard care. The interventions were delivered through remarkably varied channels—Telegram channels, digital rehabilitation platforms, telephone reminders, home visits and bedside counseling—demonstrating that health education can be scaled flexibly and cheaply. The authors note that more frequent and intense interventions produced greater effects, that multidisciplinary teams involving nurses and other professionals could optimize outcomes, and that better-educated patients make more informed decisions about renal replacement therapy. Given that chronic kidney disease already consumes enormous healthcare resources and that its clinical and economic burden is projected to grow through 2027, teaching patients to understand and manage their own disease may prove one of the highest-yield investments available—provided that larger, prospectively registered trials with consistent instrumentation can confirm what these twelve studies only suggest.

Subject of Research: The impact of health education interventions on quality of life in patients with chronic kidney disease

Article Title: Impact of health education on quality of life in patients with chronic kidney disease

Article References: Vicente-Garrido, C., Vicente García, T., Sánchez Aguadero, N., González Sánchez, J., Alonso Domínguez, R., Recio Rodríguez, J. I., Bermejo Gil, B., Coello González, E., & Sánchez-Tocino, M. L. (2026). Impact of health education on quality of life in patients with chronic kidney disease. iScience, 29(10), Article 117555. https://doi.org/10.1016/j.isci.2026.117555

Image Credits: AI Generated

DOI: 10.1016/j.isci.2026.117555

Keywords: chronic kidney disease, health education, quality of life, systematic review, hemodialysis, patient self-management, nutrition education, physical activity, digital health, emotional intelligence, renal replacement therapy, GRADE certainty

The study, conducted between 2022 and 2023 using a constructivist grounded theory approach, did not simply ask clinicians to describe their routines. Researchers used semi-structured interviews lasting 45 to 60 minutes, supplemented with hypothetical patient vignettes that allowed participants to reason through realistic cases without feeling personally exposed. Data collection and analysis ran in parallel, with each interview transcribed verbatim and coded line by line using constant comparison, a process supported by MAXQDA software. From this iterative analysis a core category emerged that captures the entire dilemma: healthcare professionals are striving to enhance cardiovascular risk awareness in their patients while balancing responsibility and uncertainty.

That balancing act begins with assessment itself. The clinicians described monitoring HbA1c, blood pressure, lipid levels and lifestyle habits, but they openly admitted that it was difficult to know which parameter best reflected a patient’s true cardiovascular risk. Some focused primarily on blood sugar; others prioritised cholesterol before turning their attention to glycaemic control. Almost all relied on risk visualisation tools from the Swedish national diabetes register, and physicians additionally used standardised instruments such as SCORE2 to classify risk as high or low. Yet the tools cut both ways. Some professionals refrained from formal risk assessment altogether because navigating multiple systems was perceived as time-consuming and cumbersome, meaning that cardiovascular risk in those cases went inadequately communicated.

Even when assessment succeeded, translation into understanding proved far harder. Participants described painstaking efforts to identify what each patient actually knew, asking individuals to explain in their own words why they were attending the visit and what they understood about their disease. They built step-by-step visual pictures, used metaphors and explanatory models to illustrate blood sugar and lipid levels, and checked comprehension by asking patients to recount what had been agreed. One diabetes nurse explained the stakes bluntly: poorly adapted information is wasted, so she tried to be clear about risks of vision changes, stroke, heart attack and kidney failure without wrapping the message too vaguely. Notably, some clinicians communicated microvascular complications while hesitating over macrovascular ones, sometimes splitting the risk message across different moments in the same visit.

The emotional dimension of this work emerged as perhaps the most striking finding. Clinicians reported genuine frustration and even feelings of failure when they could not reach certain patients, and some described the painful necessity of prioritising those willing to attempt change over those who were not, a decision one nurse called very difficult to make. Patients who expressed shame at missing treatment targets posed a particular challenge, as did patients perceived as fearful, overwhelmed by information, or struggling with mental health difficulties, in whose cases some professionals admitted avoiding risk discussions altogether. The clinicians walked a constant tightrope between encouragement and demand, wanting to convey seriousness without resorting to scare tactics or blame, and recognising that fear alone rarely produces sustainable lifestyle change.

Trust emerged as the currency that made any of this possible. Participants described building professional yet personal relationships, drawing on their own experiences, offering advice anchored in the patient’s actual life, and reinforcing progress to instil hope. Continuity was identified as crucial, because trust accumulates over repeated encounters rather than single appointments. Yet the organisational reality worked against this ideal. Many patients received only one visit per year instead of the guideline-recommended two, appointments became checklist-oriented and conveyor-belt-like, and limited time for follow-up questions hindered meaningful dialogue. Some clinicians encouraged patients to write down questions for their next visit as a workaround, a small and telling adaptation to systemic shortage.

Beneath the individual struggles lay a deeper structural problem: the diabetes team, in any meaningful sense, often did not exist. Diabetes specialist nurses described feeling alone in carrying overall responsibility for patients with type 2 diabetes, absorbing duties that would ordinarily fall to physicians because of chronic doctor shortages. Patients rarely met a physician in a planned manner, and nurses and doctors sometimes applied different strategies to the same patient, creating uncertainty about how treatment and risk communication should proceed. Some nurses admitted they did not always trust the clinical decisions of the physicians they worked with. Both professions called for shared responsibility, a common working model, structured diabetes-focused meetings and greater consensus, so that patients would hear consistent information from every member of the team.

The study’s authors argue that these findings reframe cardiovascular risk communication not as a simple transfer of information but as an ongoing, dynamic dialogue shaped in real time by the tension between objective medical data and patients’ subjective interpretations. Risk calculators and visual tools, however sophisticated, proved insufficient on their own to raise awareness or change behaviour, which helps explain why patients so often report not receiving or not understanding risk information. The researchers suggest that person-centred communication requires more than adapting facts to individual patients; it demands creating shared meaning about what risk actually signifies for a particular life, listening to patient narratives and addressing emotional and existential concerns before expecting behavioural change to follow.

The implications reach well beyond northern Sweden. The authors acknowledge limitations, including recruitment difficulties that forced reliance on snowball and convenience sampling, a predominantly female participant pool, and digital interviews that may have limited rapport, but they note that similar themes emerged across participants of varying age, sex, experience and setting, suggesting robust consistency. Their recommendations are pointed: healthcare systems must provide clinicians with the time, continuity, staffing and team structures without which even the most skilled communicator cannot succeed, and future research should explore collaboratively with patients how cardiovascular risk can be conveyed without vagueness or threat. Until then, the professionals on the front line of the diabetes epidemic will continue doing what this study documents so vividly: shouldering an enormous communicative burden alone, hoping their words reach patients before a heart attack makes the message unmistakably clear.

Subject of Research: Cardiovascular risk communication to people with type 2 diabetes in primary healthcare

Article Title: Primary Healthcare Professionals' Perspectives on Cardiovascular Risk Communication to Persons With Type 2 Diabetes: A Grounded Theory Study

Article References: Stenlund, A.-L., Hellström Ängerud, K., Lilja, M., Otten, J., & Jutterström, L. (2026). Primary Healthcare Professionals' Perspectives on Cardiovascular Risk Communication to Persons With Type 2 Diabetes: A Grounded Theory Study. Nursing Open, 13(9), Article e70828. https://doi.org/10.1002/nop2.70828

Image Credits: AI Generated

DOI: 10.1002/nop2.70828

Keywords: type 2 diabetes, cardiovascular risk, risk communication, primary healthcare, grounded theory, diabetes specialist nurses, person-centred care, patient self-management, healthcare teams, Sweden, qualitative research, HbA1c